• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.

作者信息

Niese D

机构信息

Department of Clinical Research and Development, Immunology, Sandoz Pharma Ltd, Basle, Switzerland.

出版信息

Transplant Proc. 1995 Apr;27(2):1849-56.

PMID:7725531
Abstract
摘要

相似文献

1
A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.
Transplant Proc. 1995 Apr;27(2):1849-56.
2
Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.新肾移植患者接受24个月治疗后，新山地明（Neoral）与山地明（Sandimmun）的安全性和耐受性比较。德国新山地明研究组
Transplant Proc. 1996 Aug;28(4):2187-8.
3
Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.新山地明（Sandimmun Neoral）在肾移植患者中的应用。国际新山地明研究组。
Transplant Proc. 1994 Oct;26(5):2928-31.
4
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.肾移植、肾/胰联合移植及单纯胰移植受者中环孢素转换为他克莫司：孟菲斯经验
Transplant Proc. 1996 Apr;28(2):995-7.
5
Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.肾移植术后发生移植肾功能延迟恢复的患者中三种不同抗淋巴细胞诱导方案的比较。
Transplant Proc. 1996 Feb;28(1):400-1.
6
Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group.老年肾移植患者中环孢素单一疗法与OKT3及环孢素对比泼尼松与环孢素作为诱导治疗的多中心随机研究。西班牙单一疗法研究组
Transplant Proc. 1994 Oct;26(5):2522-4.
7
Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.肾移植中OKT3与抗胸腺细胞球蛋白作为诱导免疫抑制剂的比较。
Transplant Proc. 1996 Jun;28(3):1973-5.
8
Clinical experience in transferring kidney transplant patients from sandimmun to sandimmun neoral--results after 6 months.将肾移植患者从山地明转换为新山地明的临床经验——6个月后的结果
Transplant Proc. 1995 Oct;27(5):2679-82.
9
Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
Transplant Proc. 1992 Feb;24(1):39-41.
10
High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Transplant Proc. 1995 Feb;27(1):1134-5.

引用本文的文献

1
Cost evaluation of basiliximab treatment for renal transplant patients in Japan.日本肾移植患者使用巴利昔单抗治疗的成本评估。
Pharmacoeconomics. 2003;21(11):791-806. doi: 10.2165/00019053-200321110-00003.
2
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述
Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.
3
Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
环孢素微乳剂（新山地明）。与标准环孢素相比，其在肾移植和肝移植中应用的药物经济学综述。
Pharmacoeconomics. 1998 Dec;14(6):691-708. doi: 10.2165/00019053-199814060-00009.
4
The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations.使用其他药物以降低环孢素的用药剂量。治疗及药物经济学考量。
Clin Pharmacokinet. 1997 May;32(5):357-67. doi: 10.2165/00003088-199732050-00002.
5
Clinical use of cyclosporin in rheumatoid arthritis.
Drugs. 1995;50 Suppl 1:26-36. doi: 10.2165/00003495-199500501-00005.
6
Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
Drugs. 1995 Nov;50(5):924-41. doi: 10.2165/00003495-199550050-00009.